Akouos Inc. is a precision genetic medicine company dedicated to developing innovative gene therapies aimed at restoring, improving, and preserving high-acuity hearing for individuals suffering from disabling hearing loss. With an estimated 466 million people globally affected by this condition and no FDA-approved therapies currently available to address its underlying causes, Akouos is focused on filling this significant gap in hearing health. The company emphasizes the importance of innovation in its approach, leveraging advanced technologies to create targeted treatments that can effectively reach the inner ear and address genetic factors contributing to hearing loss.

Central to Akouos's mission is the understanding that genetics play a crucial role in hearing health. The company is committed to utilizing genetic testing and counseling to better understand and treat sensorineural hearing loss, which is often linked to genetic mutations. By integrating precision medicine into their therapeutic strategies, Akouos aims to provide personalized solutions that cater to the unique genetic profiles of individuals, ultimately enhancing the quality of life for those affected by hearing impairments. Through their dedicated team and innovative technology platform, Akouos is poised to make significant advancements in the field of hearing restoration.

United States

Akouos is a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for people worldwide who live with disabling hearing loss.

Akouos Inc.

Company Details